Back to search
FDAFDA · Food and drugs·Recall number D-502-2013

DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-32

Published June 12, 2013 · Recall initiated: April 30, 2013

Summary

FDA records drug Class II recall D-502-2013, published June 12, 2013 and initiated April 30, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 44,748 bags; Lot: Lot 11-309-KL. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.

What to do

Voluntary: Firm initiated · Letter

Get an email if DOBUTAMINE IN DEXTROSE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DOBUTAMINE IN DEXTROSE
Manufacturer
Hospira Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot 11-309-KL
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-32 recalled?

Yes. FDA published recall D-502-2013 on June 12, 2013. Reported hazard: Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DOBUTAMINE IN DEXTROSE.